DoctorsProofNPPES directory · verify at state boards

Pulmonary Disease in Fullerton, CA

4 verified pulmonary disease doctors in Fullerton.

Pulmonologists diagnose and treat diseases of the lungs and respiratory system, such as asthma, COPD, and sleep apnea.

NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.

Verify a license at the Medical Board of California

Dr. Dana Tran, MD

Pulmonary Disease

19 yrs NPPES
NPI 1164566311
2141 N HARBOR BLVD STE 25000, Fullerton, CA 92835(714) 626-8669
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $264.73 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$264.73

Total received

7

Transactions

4

Paying companies

Top paying companies

Actelion Pharmaceuticals US, Inc.$190.53
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)$32.15
Pfizer Inc.$24.97
E.R. Squibb & Sons, L.L.C.$17.08

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 68th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Dana Tran do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Julie Yoo, MD

Pulmonary Disease

14 yrs NPPES
NPI 1760742001
2141 N HARBOR BLVD STE 25000, Fullerton, CA 92835(714) 626-8650
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $13,275 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$13,275

Total received

27

Transactions

6

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$12,939
Boehringer Ingelheim Pharmaceuticals, Inc.$205.80
Actelion Pharmaceuticals US, Inc.$41.12
AstraZeneca Pharmaceuticals LP$36.37
Regeneron Healthcare Solutions, Inc.$26.58
Pfizer Inc.$25.61

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 94% of that group — among the highest recipients.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Julie Yoo do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Paul Simpson, MD

Pulmonary Disease

13 yrs NPPES
NPI 1104169978
2501 E CHAPMAN AVE STE 225, Fullerton, CA 92831(714) 481-0172
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Mohamad Abdelfattah, MD

Pulmonary Disease

12 yrs NPPES
NPI 1134539711
2501 E CHAPMAN AVE, Fullerton, CA 92831(714) 481-0172
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $72.50 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$72.50

Total received

3

Transactions

1

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$72.50

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 55th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Mohamad Abdelfattah do not imply any wrongdoing. Many are meals, education, or research support.

Pulmonary Disease in Fullerton, CA — Verified | DoctorsProof | DoctorsProof